About this episode:
In this podcast, Dr Penny Heaton, Global Head of the Johnson and Johnson Office of the Chief Medical Officer, discusses:
- J&J’s approach to patient centricity across the enterprise
- Her thoughts on balancing balancing safety and risk/benefit ratios with more engaged patients and more complex science
- Moving risk benefit assessments earlier into clinical development and the necessary change management
- Incorporating multiple streams of data for the purpose of creating medicines that truly address patient needs in the real world
For more information, go to patientsaspartnersconference.com.
Related Podcasts
View All
Using Patient Engagement and Digital Innovation to Elevate Patient Insights and Outcomes
J&J Office of the Chief Medical Officer on Integrating Patient Centricity Across the Enterprise
The Role of Patient Organizations in Increasing Representation at the Clinical Trial Site Level


